All In Biotech

Drug Trial Radar · NCT01459081

Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China

Randomised, Double-blind, Placebo-controlled Trial of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China

Last checked: Nov 20, 2026Latest source record: Jan 16, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 298 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

298

Actual

Start

Oct 2011

Primary completion

Dec 2012

Study completion Dec 2012

Sponsor

Sponsor type
Industry
First posted
Oct 25, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this study is to evaluate the clinical efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections in China.

Conditions

  • Influenza A Virus Infection
  • Influenza B Virus Infection

Interventions

  • ZanamivirDrug

    10 mg inhaled by mouth, twice daily, for 5 days

  • PlaceboDrug

    inhaled by mouth, twice daily, for 5 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to alleviation of clinically important symptomsTime frame: up to 21 days

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • The Third Xiangya Hospital Of Central South University

    Changsha, China

  • West China Hospital, Sichuan University

    Chengdu, China

  • The First People's Hospital of Hangzhou

    Hangzhou, China

  • The Affiliated Hospital of Inner Mongolia Medical College

    Hohhot, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, China

  • The First Affiliated Hospital of Nanjing Medical University

    Nanjing, China

  • Qingdao Municipal Hospital

    Qingdao, China

  • Shanghai 6th People's Hospital

    Shanghai, China

  • Shanghai Changzheng Hospital

    Shanghai, China

  • ShengJing Hospital of China Medical University

    Shenyang, China

  • Tangdu Hospital Affiliated to the Fourth Military Medical University

    Xi'an, China

  • Northern Jiangsu People's Hospital

    Yangzhou, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.